Business news
- South Korea auto stocks rise after U.S. Commerce Secretary confirms tariffs lowered to 15% - Overnight, bitcoin plunged around 6% to trade below $86,000, marking its worst day since March and pressuring the broader stock market down.
- Costco sues for Trump tariff refunds before Supreme Court rules on if they're illegal - Costco joins dozens of other companies that are seeking to protect their rights to refunds of Trump's tariffs without first waiting for the Supreme Court.
- Apple names former Microsoft, Google exec to succeed retiring AI chief - Apple's AI chief is stepping down after experts say the company has fallen behind its peers when it comes to investing in AI data centers, chips and models.
- Kalshi makes move to court crypto traders with tokenized betting contracts - Tokenization refers to creating a digital version of a real-world financial asset such as a stock, bond or treasury note.
- Shopify outage: Shopping platform goes down for some users during Cyber Monday - Select merchants were unable to log in to Shopify, while others couldn't access their point-of-sale systems, the company said.
- As regime change looms at the Fed, one candidate emerges as frontrunner for chair - President Donald Trump knows who he's going to select as the next Federal Reserve chair but isn't saying yet.
- Appeals court disqualifies Trump's N.J. prosecutor pick Alina Habba, rejecting DOJ challenge - The ruling affirming Habba's disqualification came one week after another Trump-picked prosecutor, Lindsey Halligan, was deemed invalidly appointed.
- OpenAI takes stake in Thrive Holdings to help accelerate enterprise AI adoption - OpenAI will embed engineering, research and product teams within Thrive Holding's companies.
- Nvidia takes $2 billion stake in Synopsys with expanded computing power partnership - TechNvidia takes $2 billion stake in Synopsys with expanded computing power partnershipPublished Mon, Dec 1 20258:09 AM ESTUpdated 2 Min AgoAshley Capoot@/in/as
- Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to access.